# A Safety and Efficacy Study of a New Eye Drop Formulation in Patients With Dry Eye Disease.

> **NCT02553772** · PHASE3 · COMPLETED · sponsor: **Allergan** · enrollment: 242 (actual)

## Conditions studied

- Dry Eye Syndromes

## Interventions

- **DRUG:** Carboxymethylcellulose Based Eye Drop
- **DRUG:** Carboxymethylcellulose Sodium 0.5%

## Key facts

- **NCT ID:** NCT02553772
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-06
- **Primary completion:** 2016-09-09
- **Final completion:** 2016-09-09
- **Target enrollment:** 242 (ACTUAL)
- **Last updated:** 2017-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02553772

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02553772, "A Safety and Efficacy Study of a New Eye Drop Formulation in Patients With Dry Eye Disease.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02553772. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*